Hemodynamic Effects of Nebivolol at Rest and on Exertion in Patients with Heart Failure

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Angiology

• Publication date

  1990-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/000331979004100904PMID 1977335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.

  1988cited by this paper
• Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.

  1988cited by this paper
• Immediate haemodynamic effects of atenolol, bopindolol and placebo: a double‐blind crossover study of the partial agonist activity of bopindolol

  1988cited by this paper
• Subacute Hemodynamic Effects of Nebivolol in Man at Rest and During Exercise

  1987cited by this paper
• Beta-blockade--rational or irrational therapy for congestive heart failure?

  1987cited by this paper
• Haemodynamic effects in man during exercise of a single oral dose of narbivolol (R 67555), a new beta‐1‐adrenoceptor blocking agent: A comparative study with atenolol, pindolol, and propranolol

  1986cited by this paper
• Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy?

  1985cited by this paper

• Exploring Sex Differences of Beta-Blockers in the Treatment of Hypertension: A Systematic Review and Meta-Analysis

  2023influential citation
• Nebivolol: Does the key lie in β3 agonism?

  2017cites this paper
• A Review of Nebivolol Pharmacology and Clinical Evidence

  2015cites this paper
• Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease.

  2014cites this paper
• Nebivolol: impact on cardiac and endothelial function and clinical utility

  2012cites this paper
• Nebivolol

  2012influential citation
• THE USE OF β-BLOCKERS IN HYPERTENSION

  2011cites this paper
• Nebivolol for the treatment of heart failure

  2011cites this paper
• Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure

  2010cites this paper
• Nebivolol in chronic heart failure: current evidence and future perspectives

  2010cites this paper
• Nebivolol: the somewhat-different beta-adrenergic receptor blocker.

  2009cites this paper
• Nebivolol: third-generation β-blockade

  2007cites this paper
• The Effect of Nebivolol and Atenolol on Renal and Systemic Haemodynamics in Hypertensive Patients

  2007cites this paper
• Nebivolol for heart failure in the elderly

  2007cites this paper
• Effects of Nebivolol versus Carvedilol on Left Ventricular Function in Patients with Chronic Heart Failure and Reduced Left Ventricular Systolic Function

  2006cites this paper
• Nebivolol: its role in the treatment of hypertension and chronic heart failure

  2006cites this paper
• Nebivolol: a review of its clinical and pharmacological characteristics.

  2006cites this paper
• Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide‐mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients

  2004cites this paper
• Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension.

  2003cites this paper
• β‐Blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long‐term effects of atenolol vs. nebivolol

  2003cites this paper
• Einfluss des β-Rezeptorantagonisten Nebivolol auf hämodynamische Parameter, Verträglichkeit und Lebensqualität bei Patienten mit chronischer Herzinsuffizienz der NYHA-Klasse II und III zur Basistherapie (Herzglykosid, ACE-Inhibitor, Diuretikum)

  2002cites this paper
• Beta-blockade in hypertension and congestive heart failure.

  2001cites this paper
• β-blockade in Hypertension and congestive heart failure

  2001cites this paper
• Effect of Nebivolol, a Novel β1-Selective Adrenoceptor Antagonist with Vasodilating Properties, on Kidney Function

  2000cites this paper
• Nebivolol in the Management of Essential Hypertension

  1999cites this paper
• Nebivolol in the management of essential hypertension: a review.

  1999cites this paper
• Clinical pharmacology of nebivolol.

  1999cites this paper
• Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents.

  1993cites this paper
• Nebivolol The Somewhat-Different (cid:1) -Adrenergic Receptor Blocker

  year unknowncites this paper